# Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

> **NCT02076269** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 15 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02076269
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02076269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02076269, "Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02076269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*